PMC:7247521 / 6440-6660
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
113 | 32-35 | Disease | denotes | XCH |
114 | 94-120 | Disease | denotes | viral infectious pneumonia |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T80 | 94-99 | NCBITaxon:10239 | denotes | viral |
T81 | 170-179 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T31 | 100-110 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T32 | 111-120 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T9 | 111-120 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T41 | 0-220 | Sentence | denotes | In our study, since MSXG, SGMH, XCH and WLS have been independently used for the treatment of viral infectious pneumonia, this study firstly screened out major effective compounds from five functional units respectively. |